JNJ — Johnson & Johnson Balance Sheet
0.000.00%
Last trade - 00:00
- $356.43bn
- $362.84bn
- $85.16bn
- 100
- 46
- 72
- 84
2019 December 29th | 2021 January 3rd | 2022 January 2nd | 2023 December 31st | 2023 January 1st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 19,287 | 25,185 | 31,608 | 22,927 | 23,519 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 14,481 | 13,576 | 15,283 | 14,873 | 16,160 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 45,274 | 51,237 | 60,979 | 53,495 | 55,294 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 18,615 | 19,766 | 19,862 | 20,898 | 20,903 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 157,728 | 174,894 | 182,018 | 167,558 | 187,378 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 35,964 | 42,493 | 45,226 | 46,282 | 55,802 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 98,257 | 111,616 | 107,995 | 98,784 | 110,574 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 59,471 | 63,278 | 74,023 | 68,774 | 76,804 |
Total Liabilities & Shareholders' Equity | 157,728 | 174,894 | 182,018 | 167,558 | 187,378 |
Total Common Shares Outstanding |